BlackRock Health Sciences Term Trust (BMEZ) To Go Ex-Dividend on August 14th

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, June 5th. Stockholders of record on Friday, August 14th will be paid a dividend of 0.11 per share on Monday, August 31st. This represents a c) dividend on an annualized basis and a dividend yield of 8.2%. The ex-dividend date is Friday, August 14th.

BlackRock Health Sciences Term Trust Stock Up 0.0%

BlackRock Health Sciences Term Trust stock opened at $16.12 on Wednesday. The stock has a 50-day simple moving average of $15.16 and a 200 day simple moving average of $14.75. BlackRock Health Sciences Term Trust has a 12-month low of $13.70 and a 12-month high of $16.20.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Institutional investors have recently modified their holdings of the stock. Rivernorth Capital Management LLC grew its stake in shares of BlackRock Health Sciences Term Trust by 24.8% during the first quarter. Rivernorth Capital Management LLC now owns 809,196 shares of the company’s stock valued at $11,620,000 after purchasing an additional 160,629 shares during the last quarter. Saba Capital Management L.P. bought a new position in BlackRock Health Sciences Term Trust in the 1st quarter worth approximately $10,907,000. Lazard Asset Management LLC lifted its holdings in BlackRock Health Sciences Term Trust by 64.2% during the 1st quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock worth $8,926,000 after buying an additional 243,054 shares in the last quarter. Quantedge Capital Pte Ltd lifted its holdings in BlackRock Health Sciences Term Trust by 85.0% during the 1st quarter. Quantedge Capital Pte Ltd now owns 135,854 shares of the company’s stock worth $1,951,000 after buying an additional 62,400 shares in the last quarter. Finally, PNC Financial Services Group Inc. bought a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at $35,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.